US Bancorp DE Invests $80,000 in Tempus AI, Inc. (NASDAQ:TEM)

US Bancorp DE bought a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 2,375 shares of the company’s stock, valued at approximately $80,000.

A number of other institutional investors also recently modified their holdings of the stock. First Horizon Advisors Inc. bought a new stake in Tempus AI in the third quarter valued at $30,000. FNY Investment Advisers LLC acquired a new stake in shares of Tempus AI in the 4th quarter valued at about $67,000. IFP Advisors Inc bought a new stake in Tempus AI in the 4th quarter valued at about $76,000. Stifel Financial Corp acquired a new position in Tempus AI during the 3rd quarter worth approximately $218,000. Finally, Mirae Asset Global Investments Co. Ltd. bought a new position in Tempus AI in the fourth quarter worth approximately $178,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

Analyst Ratings Changes

TEM has been the subject of several recent research reports. Wolfe Research downgraded Tempus AI from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 26th. Loop Capital decreased their price target on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a research note on Tuesday, January 14th. Guggenheim reaffirmed a “buy” rating on shares of Tempus AI in a research note on Tuesday, February 25th. JPMorgan Chase & Co. downgraded shares of Tempus AI from an “overweight” rating to a “neutral” rating and boosted their target price for the stock from $50.00 to $55.00 in a research report on Tuesday, February 25th. Finally, Morgan Stanley raised their price target on shares of Tempus AI from $50.00 to $60.00 and gave the company an “overweight” rating in a research report on Thursday, March 6th. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $61.18.

Tempus AI Stock Performance

Shares of NASDAQ TEM opened at $49.87 on Tuesday. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. The stock’s 50 day moving average price is $55.51 and its 200-day moving average price is $51.60. Tempus AI, Inc. has a twelve month low of $22.89 and a twelve month high of $91.45.

Insider Buying and Selling

In other news, Director Jennifer A. Doudna sold 1,320 shares of the firm’s stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $90.00, for a total transaction of $118,800.00. Following the completion of the sale, the director now owns 36,011 shares in the company, valued at $3,240,990. This trade represents a 3.54 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, major shareholder Bradley A. Keywell sold 170,720 shares of Tempus AI stock in a transaction that occurred on Wednesday, January 15th. The stock was sold at an average price of $35.45, for a total transaction of $6,052,024.00. Following the completion of the sale, the insider now directly owns 15,993,729 shares in the company, valued at $566,977,693.05. This trade represents a 1.06 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 5,749,469 shares of company stock worth $322,529,733.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.